StartupsFinSMEsabout 2 hours ago
FORE Biotherapeutics Raises $67.4M Series D-2
1 min read
FORE Biotherapeutics raised $67.4 million in a Series D-2 extension funding round. The financing will support the company's clinical development programs. The round included participation from new and existing investors.
Level
Hype check
Tap to vote and see what everyone thinks.
